- Global Pharma News & Resources

The Neurotrauma Treatment market to be under the gambit of “growth curve” in the next decade

Neurotrauma is brain and spinal cord injury, a critical health problem which needs the attention of world health communities. The injury to the brain and spinal cord can cause enormous losses to the patient and his family. Neurotrauma can result in death or permanent disabilities. Neurotrauma treatment is a long term care programme. Neurotrauma treatment requires highly qualified medical expertise and responsiveness.  In general, there are two types of neurotrauma viz. spinal trauma and brain trauma. Spinal trauma is the damage to the spinal cord due to injury. Researchers are focusing to promote the nerve cell regeneration for the neurotrauma treatment of spinal injuries, but still, spinal cord injury cannot be reversed completely.  Traumatic brain injury occurs when the head is violently and suddenly hits an object which damages the brain tissues. At the initial stage, the medical professional will try to stabilize the traumatic brain injuries. Neurotrauma treatment for brain requires the proper oxygen supply to the brain and rest of the body, control the blood pressure and maintain the adequate blood flow.

The rising number of traumatic brain injuries is the primary factor driving the growth of neurotrauma treatment market. Also, the increasing number of accident cases which damages the spine and brain is responsible for robust progress of neurotrauma treatment market. Additionally, a high focus of neurosurgeons and other brain specialists to promote nerve regeneration therapy for spinal injuries will upsurge the demand for neurotrauma treatment. The launch of MRI-guided laser ablation platforms and MRI Interventions neurosurgical navigation platform will also propel the revenue growth of neurotrauma treatment market over the forecast period. The shortage of neurosurgical workforce will retrain the progress of neurotrauma treatment market to some extent. Also, the lack of awareness among the people in the under developing economies about neurotrauma programme will also hamper the revenue growth of neurotrauma treatment market.

To remain ‘ahead’ of your competitors, request for a sample here@

The global neurotrauma treatment market is classified on the basis of treatment type, indication, end user and region.

Based on treatment type, neurotrauma treatment market is segmented into the following:

  • Cranioplasty
  • Kyphoplasty
  • Halo stabilization
  • Spinal decompression
  • Lumbar drain placement
  • Complex craniofacial repair
  • Others

Based on indication, neurotrauma treatment market is segmented into the following:

  • Brain Trauma
  • Spine Trauma

Based on end user, neurotrauma treatment market is segmented into the following:

  • Hospitals
  • Neurotrauma Care Centers
  • Long Term Care Centers
  • Rehabilitation Centers

To receive extensive list of important regions, Request Methodology here @

The neurotrauma treatment market is expected to significant growth over the forecast period owing rise in the number of neurotrauma cases throughout the globe. According to Barrow Neurosurgical Institutes, approximately 1.5 million people in the U.S. suffer from traumatic brain injury every year. The same study also estimates that roughly 11,000 citizens of U.S. are admitted to hospitals annually due to spinal cord injury. By treatment type, cranioplasty and kyphoplasty are most widely performed for the neurotrauma treatment, hence these segments are expected to gain the majority of revenue share for neurotrauma treatment market. Among both indication, brain trauma segment will gain more revenue share than spinal trauma share for neurotrauma treatment market. Based on end user, hospitals is the lucrative segment for neurotrauma treatment market while neurotrauma care centers segment is projected to grow at a significant pace than other end users of neurotrauma treatment market.

North America is the dominant region by revenue share owing to the rising adoption of nerve cell repair therapy for neurotrauma treatment in the U.S. and Canada. After North America, Europe, and East Asia region is expected to gain the revenue share of the neurotrauma treatment market. High adoption of neurotrauma programme in the U.K., Germany, France, Italy, Spain other European countries is the key factor behind the growth of the neurotrauma treatment market in Europe. South Asia and East Asia region is expected to show rapid growth over the forecast period for the neurotrauma treatment market due to the rising number of cases of traumatic brain injuries in India, China, and Japan. Middle & Africa and Latin America are expected to show the delayed growth for the neurotrauma treatment market owing to low awareness among the people in this geographies.

You Can Request for TOC Here@

Explore Extensive Coverage of PMR`s 

Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved Beg
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –


Editor Details

Last Updated: 10-Nov-2020